VITRASERT vs ZIRGAN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Attribute	VITRASERT	ZIRGAN
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	GANCICLOVIR	GANCICLOVIR
Manufacturer	Bausch and Lomb	Bausch and Lomb
Dosage forms	Implant	Topical
Drug class	Cytomegalovirus Nucleoside Analog Dna Polymerase Inhibitor	Cytomegalovirus Nucleoside Analog Dna Polymerase Inhibitor
Boxed warning	None	None
Treats	Aids-Related Opportunistic Infections, Cytomegalovirus Retinitis	Aids-Related Opportunistic Infections, Cytomegalovirus Retinitis

vitrasert zirgan

Rating

New

Pharmacy pays

—

Type

Active ingredient

GANCICLOVIR

Manufacturer

Bausch and Lomb

Dosage forms

Implant

Topical

Drug class

Cytomegalovirus Nucleoside Analog Dna Polymerase Inhibitor

Boxed warning

None

Treats

Aids-Related Opportunistic Infections, Cytomegalovirus Retinitis

Frequently asked questions

What is the difference between Vitrasert and Zirgan?

Both Vitrasert and Zirgan share the active ingredient Ganciclovir.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.